Display options
Share it on

Int J Alzheimers Dis. 2010 Dec 19;2011:431320. doi: 10.4061/2011/431320.

E22Δ Mutation in Amyloid β-Protein Promotes β-Sheet Transformation, Radical Production, and Synaptotoxicity, But Not Neurotoxicity.

International journal of Alzheimer's disease

Takayuki Suzuki, Kazuma Murakami, Naotaka Izuo, Toshiaki Kume, Akinori Akaike, Tetsu Nagata, Tomoyuki Nishizaki, Takami Tomiyama, Hiroshi Takuma, Hiroshi Mori, Kazuhiro Irie

Affiliations

  1. Laboratory of Organic Chemistry in Life Science, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.

PMID: 21234376 PMCID: PMC3017891 DOI: 10.4061/2011/431320

Abstract

Oligomers of 40- or 42-mer amyloid β-protein (Aβ40, Aβ42) cause cognitive decline and synaptic dysfunction in Alzheimer's disease. We proposed the importance of a turn at Glu22 and Asp23 of Aβ42 to induce its neurotoxicity through the formation of radicals. Recently, a novel deletion mutant at Glu22 (E22Δ) of Aβ42 was reported to accelerate oligomerization and synaptotoxicity. To investigate this mechanism, the effects of the E22Δ mutation in Aβ42 and Aβ40 on the transformation of β-sheets, radical production, and neurotoxicity were examined. Both mutants promoted β-sheet transformation and the formation of radicals, while their neurotoxicity was negative. In contrast, E22P-Aβ42 with a turn at Glu22 and Asp23 exhibited potent neurotoxicity along with the ability to form radicals and potent synaptotoxicity. These data suggest that conformational change in E22Δ-Aβ is similar to that in E22P-Aβ42 but not the same, since E22Δ-Aβ42 exhibited no cytotoxicity, unlike E22P-Aβ42 and wild-type Aβ42.

References

  1. J Biol Chem. 2009 Feb 20;284(8):4749-53 - PubMed
  2. J Am Chem Soc. 2005 Oct 5;127(39):13472-3 - PubMed
  3. J Am Chem Soc. 2005 Nov 2;127(43):15168-74 - PubMed
  4. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1470-4 - PubMed
  5. Nat Struct Mol Biol. 2007 Dec;14(12):1157-64 - PubMed
  6. Brain Res. 1997 May 9;756(1-2):200-4 - PubMed
  7. Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 - PubMed
  8. Chembiochem. 2007 Dec 17;8(18):2308-14 - PubMed
  9. Cell. 1994 Jun 17;77(6):817-27 - PubMed
  10. J Biol Chem. 2003 Nov 14;278(46):46179-87 - PubMed
  11. Neuroreport. 2008 Apr 16;19(6):615-9 - PubMed
  12. Biochem Biophys Res Commun. 2008 Feb 15;366(3):745-51 - PubMed
  13. Curr Med Chem. 2003 Dec;10(24):2651-9 - PubMed
  14. J Biol Chem. 2003 Jun 27;278(26):23221-6 - PubMed
  15. J Neurosci. 2010 Apr 7;30(14):4845-56 - PubMed
  16. Nat Rev Drug Discov. 2004 Mar;3(3):205-14 - PubMed
  17. Methods Enzymol. 1999;309:305-18 - PubMed
  18. Chembiochem. 2009 Jan 26;10(2):287-95 - PubMed
  19. Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S169-79 - PubMed
  20. ACS Chem Neurosci. 2010 Nov 17;1(11):747-56 - PubMed
  21. Brain Res Mol Brain Res. 2000 Aug 14;80(1):53-62 - PubMed
  22. Biochem Biophys Res Commun. 2002 May 31;294(1):5-10 - PubMed
  23. Nat Med. 2008 Aug;14(8):837-42 - PubMed
  24. Nature. 2002 Apr 4;416(6880):535-9 - PubMed
  25. Brain Res. 2000 Jan 10;852(2):279-89 - PubMed
  26. Am J Pathol. 2009 Mar;174(3):957-69 - PubMed
  27. Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12 - PubMed
  28. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 - PubMed
  29. Ann Neurol. 2008 Mar;63(3):377-87 - PubMed
  30. J Mol Biol. 1977 Sep 15;115(2):135-75 - PubMed
  31. Expert Rev Mol Med. 2009 Jun 03;11:e17 - PubMed
  32. J Am Chem Soc. 2001 Jun 20;123(24):5625-31 - PubMed

Publication Types